Close Menu

Making Their Move

The pharmacy-benefit managers Medco and CVS Caremark may soon take over the genetic testing business as they did the prescription business, says Technology Review. Medco bought up DNA Direct and CVS now has a larger stake in Generation Health. Tech Review says that Medco is targeting the gaps in physicians' and patients' knowledge — their pharmacists call up, offer a genetic test for the prescribed drug, and help interpret the results.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.